|
FAP |
AFAP/HFAS |
HNPCC/Lynch |
UCAN |
Mean age at diagnosis ofcolorectal cancer |
32-39 |
45-55 |
42-49 |
40-70 |
Distribution of cancer |
Random |
Mainly right colon |
Mainly right colon |
Mainly left colon |
No of polyps |
>100 |
1-100 |
1 (ie tumour) |
|
Sex ratio (male:female) |
1:1 |
1:1 |
1.5:1 |
1:1 |
Endoscopic view of polyp |
Pedunculated |
Mainly flat |
Pedunculated (45%); flat (55%) |
None |
Lag time (years) from early adenoma to occurrence of cancer |
10-20 |
10 |
5 |
?<8 |
Proportion (%) of colonic cancer |
1 |
0.5 |
1-5 |
<0.5 |
Superficial physical stigmata |
80% have retinal pigmentation |
None |
Only in Muir-Torre syndrome |
None |
Distribution of polyps |
Distal colon or universal |
Mainly proximal to splenic flexure with rectal sparing |
Mainly proximal to splenic flexure |
None |
Carcinoma histology |
More exophytic growth |
Non-exophytic but very variable |
Inflammation increased mucin |
Mucosal ulceration and inflammation |
Other associated tumours |
Duodenal adenoma cerebral and thyroid tumours, medulloblastoma and desmoids |
Duodenal adenoma |
Endometrial ovarian, gastric cancer, glioblastoma, many other cancers |
|
Gene (chromosome) mutation |
APC (5q 21) distal to 5′ |
APC (5q 21) proximal to 5′ |
MHS2 (2p), MLH1 (3p21), PMS1 (2q31), PMS2 (7p22) |
Multiple mutations, 17p (p53), 5q (APC), 9p (p16) |